![](https://investorshub.advfn.com/uicon/17032.png?cb=1632313312)
Sunday, October 20, 2019 1:31:45 PM
As always, appreciate all your DD and all your insight.
Joe Edelman's position says a great deal because he loves to find these nuggets and expand his position as he becomes more and more confident in them and he obviously believes Foamix is one of them.
This is from an article about him from 2013 ... "BACKED BY SIX pharmaceutical-industry analysts, the 58-year-old Edelman is known for selecting the right products. "The critical thing we are doing is evaluating the science and the data to decide whether a drug will work and whether it will be approved," says Edelman, adding that he focuses mostly on early clinical information. "If we think there is a higher probability that a drug will work than the Street does, we may have a long on that position."
THANKS again for sharing tdeck ! ... ;)
John
... JMHO
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM